Home Analyst Ratings AstraZeneca PLC Upgraded to Add at AlphaValue

AstraZeneca PLC [AZN] Upgraded to Add at AlphaValue

AlphaValue took its AstraZeneca PLC [NASDAQ:AZN]‎‎ rating to the equivalent of Add from Reduce,‎ in a ‎research note dated December 30, 2020. Other analysts also revised their coverage, with Morgan ‎Stanley’s analysts upgrading the shares from ‎‎”an Equal-weight” rating to “an Overweight” rating in a ‎research note to investors issued in early ‎December. Meanwhile, UBS had raised its rating on AZN to ‎‎”Neutral” from the earlier “Sell”, in a ‎research note produced for clients November 30, 2020. In ‎addition, there was an upgrade from HSBC ‎Securities on November 11, 2020. The rater changed AZN ‎from “a Reduce” to “a Hold”.

Get the hottest stocks to trade every ‎day before the market opens 100% ‎free. Click here now. 

Is AstraZeneca PLC [NASDAQ:AZN] a Good Buy Right Now?

It should be noted that ‎AZN ‎technical indicators for short, intermediate as well as long term progress have placed an ‎overall ‎average of 72% as Sell. The average signal changed from 56% Sell in the last week and compares ‎with ‎‎16% Sell in the past month. Data from AstraZeneca PLC’s Trend Spotter indicated that the signals ‎were ‎Weakest. The stock current average is 13.81 million shares in the past 20 days and the short ‎term ‎average signal indicates a 100% Sell. In the last 50 days, the average trading volume was 9.26 ‎million ‎shares while the medium term average advocated for 50% Sell. The average long-term signal ‎stands at ‎‎50% Sell and the 100-day average volume stands at 6.69 million shares.‎‎

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

AZN Price Performance

On Wall Street, AstraZeneca PLC [NASDAQ:AZN] finished ‎Tuesday’s ‎session up 1.05% at $49.90. The stock went up to $50.7001 at the same session while its ‎lowest single ‎day price was $49.785. In the last five days, it saw a rise of about 0.44%, AstraZeneca PLC ‎shares gained ‎by almost 0.08% since the beginning of the year. However, the share price has dropped ‎to as low as -‎‎23.16% below its one year high. On 07/20/20, the company shares recorded $64.94, the ‎highest single-‎day price it has got to in the last 52-weeks and a 52-week low was seen on 03/16/20, the ‎same year at ‎‎$36.15. The company’s shares have declined by -0.22% in the past year. The 50-day SMA ‎achieved is ‎‎$52.83 while the 200-day SMA is $52.78. Volume gained to 17.31 million from 15.48 million in ‎the ‎previous session.‎‎

AstraZeneca PLC [AZN] Valuation Measures

Notably, AstraZeneca PLC [AZN] stock ‎cannot ‎be classified as a good candidate in the listing of underestimated low-priced Drug ‎Manufacturers – ‎General companies to purchase soonest possible with the prevailing 12-month PE ‎ratio of 52.47. The ‎measure means the stock is exchanging at a premium as compared to the 24.38x ‎trailing earnings of ‎the industry. It can be helpful for investors to consider historical price-sales ratio, ‎more specifically, a ‎‎5.03 PS value ratio is reported for the last one year of reported earnings. That is ‎higher than the ‎industry average of 2.83 which means AZN serve an unattractive investment ‎opportunity compared to ‎its competitors.‎‎

AZN Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing ‎is ‎perceived around 49.56 level, and in case of violation of this particular level, it will cause more drop ‎to ‎‎49.21 level. On the upper level, 51.04 is still the key resistance. The stock may increase to ‎the ‎subsequent resistance at 50.47. The Relative Strength Index (RSI) pinned on the 14-day chart is ‎‎40.62, ‎implying a neutral technical stance while the MACD stands at -1.45, meaning price will decrease ‎in the ‎next trading period. Percent R indicator moved to 74.73%, implying bearish price ‎movement. ‎Stochastic %K at 15.97% suggest selling the stock.‎‎

What is the short interest in AstraZeneca PLC?

Short interest in the AstraZeneca PLC ‎stock ‎has surged, increasing by 2.83 million shares to total 3.46 million shares on Dec 14, 2020. The ‎interest ‎had seen shares on Nov 12, 2020 stand at 6.29 million, data from Yahoo Finance shows. The ‎decrease ‎of -81.79% suggests the stock saw some decreased bullish sentiment. ‎‎

AstraZeneca PLC’s Biggest Shareholders: Who Owns AstraZeneca PLC [AZN]?

Filings ‎by ‎Wellington Management Co. LLP showed that the firm now holds a total of 52,093,683 shares ‎or ‎roughly 1.99% of the outstanding AZN shares. This means their shares have reduced by -‎‎2,450,834 ‎from the 52,093,683 the investor reportedly held in its prior 13-F filing. With the conclusion of ‎the sale, ‎PRIMECAP Management Co. updated stake is worth $2,726,307,349. Details in the latest 13F ‎filings ‎reveal that Fidelity Management & Research Co disposed off their -7.19% stake valued ‎at ‎‎$2,273,213,212 while Jennison Associates LLC cut theirs at $1,643,017,147. During the last ‎quarter, ‎Fidelity Management & Research Co liquidated -3,328,789 of its shares in AstraZeneca PLC ‎while ‎Jennison Associates LLC sold -8,098,278 shares. The Capital Research & Management Co’s ‎holdings ‎currently number 29,249,466 shares at $1459548353.4. According to the firm’s last 13F report, ‎Fisher ‎Asset Management LLC shares in the company at filing stood at 17,342,680 shares, ‎roughly ‎‎$918,121,479.‎‎

AZN Earnings Forecast For The Current Quarter

AstraZeneca PLC [AZN] is expected to ‎report ‎strong earnings results for the quarter ending on Dec 2020. Consensus estimates give the ‎company ‎expected revenues of $7.01B and an earnings per share of $0.64 for Dec 2020. Looking ‎further ahead, ‎the company is expected to report revenue of $6.82B at an EPS of $0 for Mar 2021. The ‎estimates ‎represent upside of 15.20% and 20.12% in the company’s revenue and earnings per ‎share, ‎respectively, on a year-on-year basis.‎‎

Get the hottest stocks to trade every day before the market ‎opens 100% ‎free. Click here now. 

AZN Earnings Estimates For The ‎Current ‎Year

For the financial year, AstraZeneca PLC [NASDAQ:AZN] is expected to bring in ‎revenue of ‎‎$26.24B. The returns are nearly $1.86 billion higher than the company’s actual revenue ‎recorded in the ‎fiscal year 2019. In terms of EPS for the 2020, estimate put it at 2.47, higher than that of ‎FY19 by $0.72. ‎Estimates put this year’s earnings growth at 41.10%, 20.20% for the next, and at an ‎annual 19.20% over ‎the next 5-year period. As for sales, forecasts are for an increase of 7.60% in the ‎current fiscal year and ‎a further 15.20% over the following year.‎

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Amarin Corporation plc (NASDAQ: AMRN) stock plunged in the premarket trading session; here’s why

In the premarket trading session, Amarin Corporation plc (AMRN) stock had plunged by -4.56% to $4.4. AMRN stock closed previous session at $4.61 gaining...

Why Second Sight Medical Products, Inc. (EYES) stock is Popping High today?

Second Sight Medical Products, Inc. (EYES) stock announced two-year results of its Orion Study after which the EYES stock price happened to be green...

Luokung Technology Corp. (LKCO) Stock Undergoes Volatility as Appeal Over CCMC Designation is Underway

Luokung Technology Corp. (LKCO) stock prices were down by 6.40% as of the market closing on May 11th, 2021, bringing the price per share...

Vista Gold Corp. (VGZ) Stock Inches Higher After Promising Q1 2021 Financial Reports

Vista Gold Corp. (VGZ) stock prices were up by an incremental 1.82% as of the market closing on May 11th, 2021, bringing the price...

Array Technologies, Inc. (ARRY) Stock Prices Stay Stable Despite Troubling Q1 2021 Financial Reports

Array Technologies, Inc. (ARRY) stock prices were up by a marginal 0.28% as of the market closing on May 11th, 2021, bringing the price...

Lucira Health Inc. (NASDAQ:LHDX) stock rallied today in the current trading session; here’s why

In the current trading session at last check, Lucira Health Inc. (LHDX) shares had surged by 15.32% to the price of $5.87. LHDX's stock...

PaySign, Inc. (PAYS) Stock Down Following Disclosure of Troubling Q1 2021 Financial Reports

PaySign, Inc. (PAYS) stock prices were down 15.0568% early in the trading day on May 12th, 2021, bringing the price per share down to...

Comstock Mining Inc. (NASDAQ:LODE) stock plunged in the current trading session; here’s why

In the current trading session at the last check, Comstock Mining Inc. (LODE) stock had plunged -3.25% to trade at $3.21. LODE stock previously...

Related News

Ocugen Inc. (NASDAQ:OCGN) stock plunged in the premarket trading session; here’s why

At last check Ocugen Inc. (OCGN) stock had plunged by-11.92% to $9.61 in premarket trading session. OCGN stock previously closed at $10.91 losing -12.79%....

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.